These final results, along with a preceding report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 guidance the thought of targeting ACKR3 as a singular strategy to modulate the opioid procedure, which could open new therapeutic avenues for opioid-connected Diseases. Strengthen much healthier immune functionality: https://cordella050rjy6.activosblog.com/profile